World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
51
Citations
8856
World Ranking
4345
National Ranking
388

Marta Boffito publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Marta Boffito sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 323 publications — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Marta Boffito D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Marta Boffito sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 51 D-Index — 23rd percentile

23% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Marta Boffito is affiliated with Imperial College London in the United Kingdom and has an extensive research record focused primarily on medicine, with a significant emphasis on infectious diseases. Their work covers multiple subfields including infectious diseases, emergency medicine, epidemiology, virology, and pediatrics, perinatology, and child health. The research topics addressed encompass HIV/AIDS research and interventions, HIV-related health complications and treatments, HIV/AIDS drug development and treatment, Pneumocystis jirovecii pneumonia detection and treatment, as well as SARS-CoV-2 and COVID-19 research and clinical studies.

The scientist has contributed to the literature with notable recent papers, such as:

  • Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational analysis, 2022, published in The Lancet Infectious Diseases
  • Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications, 2022, Clinical Pharmacology & Therapeutics
  • Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial, 2022, EClinicalMedicine
  • Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial, 2022, Clinical Infectious Diseases
  • BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022, HIV Medicine

Boffito frequently collaborates with other researchers, including Jaime H. Vera, Caroline Sabin, Patrick Mallon, Alan Winston, and Frank A. Post. These collaborations have contributed to the breadth and depth of their research output.

Their publications appear predominantly in journals that specialize in HIV and infectious diseases. The most frequent publication venues include:

  • HIV Medicine
  • AIDS
  • International Journal of STD & AIDS
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Lancet HIV

The main fields of study for Boffito are centered on medicine, with 296 publications specifically recorded. The distribution across subfields illustrates a strong focus on infectious diseases, accounting for 128 publications, followed by emergency medicine with 45 publications, epidemiology with 42, virology with 27, and 11 publications in pediatrics, perinatology, and child health.

Key research topics in their work include:

  • HIV/AIDS Research and Interventions
  • HIV-related health complications and treatments
  • HIV/AIDS drug development and treatment
  • Pneumocystis jirovecii pneumonia detection and treatment
  • HIV Research and Treatment
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies

Best Publications

  • British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008

    B G Gazzard;Jane Anderson;Abdel Babiker;Marta Boffito

  • Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.

    Paul T. Heath;Eva P. Galiza;David N. Baxter;Marta Boffito

  • Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    P W Horby;M Campbell;E Spata;Emberson

  • British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012

    Ian Williams;Duncan Churchill;Jane Anderson;Marta Boffito

  • British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.).

    Ian Williams;Ian Williams;Duncan Churchill;Jane Anderson;Marta Boffito

  • British HIV Association guidelines for the routine investigation and monitoring of adult HIV‐1‐infected individuals 2011

    D Asboe;C Aitken;M Boffito;C Booth

  • Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial

    Unknown

  • Protein binding in antiretroviral therapies.

    Marta Boffito;David J. Back;Terrence F. Blaschke;Malcolm Rowland

  • Rapid initiation of antiretroviral therapy at HIV diagnosis: definition, process, knowledge gaps

    Unknown

  • Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs

    Marta Sousa;Anton Pozniak;Marta Boffito

  • Antiretrovirals and the kidney in current clinical practice: renal pharmacokinetics, alterations of renal function and renal toxicity.

    Jean Cyr Yombi;Anton Pozniak;Marta Boffito;Rachael Jones

  • The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.

    Mark Bower;Justin Weir;Nicholas Francis;Tom Newsom-Davis

  • A Compartmental Pharmacokinetic Evaluation of Long‐Acting Rilpivirine in HIV‐Negative Volunteers for Pre‐Exposure Prophylaxis

    A G A Jackson;L J Else;P M M Mesquita;D Egan

  • Increasing use of 'party drugs' in people living with HIV on antiretrovirals: a concern for patient safety.

    Margherita Bracchi;David Stuart;Richard Castles;Saye Khoo

  • Proof of Activity with AMD11070, an Orally Bioavailable Inhibitor of CXCR4-Tropic HIV Type 1

    Graeme Moyle;Edwin DeJesus;Marta Boffito;Rebecca S. Wong

  • Current status and future prospects of therapeutic drug monitoring and applied clinical pharmacology in antiretroviral therapy.

    Marta Boffito;Edward Acosta;David Burger;Courtney V. Fletcher

  • British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015

    Duncan Churchill;Laura Waters;Nadia Ahmed;Brian Angus

  • Long-acting antiviral agents for HIV treatment.

    David A. Margolis;Marta Boffito

  • Pharmacokinetics and antiretroviral response to darunavir/ritonavir and etravirine combination in patients with high-level viral resistance.

    Marta Boffito;Alan Winston;Akil Jackson;Carl Fletcher

  • Pharmacokinetics, efficacy, and safety of darunavir/ritonavir 800/100 mg once-daily in treatment-naïve and -experienced patients.

    Marta Boffito;Diego Miralles;Andrew Hill

  • Atazanavir enhances saquinavir hard-gel concentrations in a ritonavir-boosted once-daily regimen.

    Marta Boffito;Michael Kurowski;Guido Kruse;Andrew Hill

  • Clinical use of lopinavir/ritonavir in a salvage therapy setting: pharmacokinetics and pharmacodynamics.

    Marta Boffito;Isabella Arnaudo;Riccardo Raiteri;Stefano Bonora

  • Early virologic failure in HIV-1 infected subjects on didanosine/tenofovir/efavirenz: 12-week results from a randomized trial.

    Desmond Maitland;Graeme Moyle;James Hand;Sundhiya Mandalia

  • Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.1.7 Variant

    Seth Toback;Paul T. Heath;Eva P. Galiza;David Baxter

Frequent Co-Authors

David Back
David Back University of Liverpool
Saye Khoo
Saye Khoo University of Liverpool
Graeme Moyle
Graeme Moyle Chelsea and Westminster Hospital NHS Foundation Trust
Anton Pozniak
Anton Pozniak London School of Hygiene & Tropical Medicine
Alan Winston
Alan Winston Imperial College London
Brian Gazzard
Brian Gazzard St Bartholomew's Hospital
Frank A. Post
Frank A. Post King's College London
Mark Nelson
Mark Nelson University of Vermont
Caroline Sabin
Caroline Sabin University College London
Giovanni Di Perri
Giovanni Di Perri University of Turin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in microbiology, exploring related online degrees can open diverse career opportunities. One option is pursuing an online medical billing and coding certificate fast, which offers a quicker route into healthcare administration, complementing scientific knowledge with practical billing expertise.

Alternatively, students may consider broader options within the healthcare field, such as various online healthcare degrees. These programs provide flexibility and accessibility while preparing graduates for roles in different medical disciplines, many of which overlap with microbiology-related fields.

For those drawn to public health, enrolling in online public health masters programs easy to get into can be a strategic move. These programs often include microbiology content within their curriculum and equip students to address health challenges on a broader scale.

Additionally, a career as a child life specialist salary with bachelor degree offers another pathway related to healthcare and patient support. This role benefits from a foundation in biological sciences, including microbiology, blending science and compassionate care.

Best Scientists Citing Marta Boffito

Trending Scientists

Recently Published Articles